PanTracer™ LBx is now available! - Order now

Webinar: Power of data & specimen archive for discovery & development View now!

CSF3R Mutation Analysis

  • Molecular
This test uses bi-directional sequencing of exons 14 and 17 of the CSF3R gene, including the T618I mutation (T595I).
Turnaround time
10 Days

Level of Service

  • Global
New York Approved: No

Clinical Significance

The Colony Stimulating Factor 3 Receptor (CSF3R) gene is mutated in 59% of chronic neutrophilic leukemia (CNL) or atypical chronic myeloid leukemia (aCML). CSF3R mutation has been reported in 30-80% of leukemia arising in patients with severe congenital neutropenia. It has also been reported in 4% of colon cancer and 3% of small cell/squamous cell lung cancer. The presence of CSF3R mutation is important for diagnosis, classification, and prognosis of chronic myeloproliferative neoplasms.

Specimen Requirements

Bone Marrow Aspirate: 2 mL in EDTA tube.
Peripheral Blood: 5 mL in EDTA tube.
Note: Test is DNA-based. Please select Extract & Hold - DNA If specimen hold service is desired.

Storage and Transportation

Use cold pack for transport, making sure cold pack is not in direct contact with specimen. For fresh samples: refrigerate before shipping and ship same day as drawn whenever possible. Do not freeze. Please select extract & hold - DNA if specimen hold service is desired.

CPT Code(s)*

81479

*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

Last Updated: August 27, 2025

Get in touch

Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.

CSF3R Mutation Analysis